Steven Gundry
Steven Gundry is a heart surgeon and functional medicine practitioner. His published medical research focuses on pediatric cardiac surgery, congenital heart disease interventions, and pediatric heart transplantation. His work has also investigated cardiac xenotransplantation models, robotically assisted surgical techniques, and surgical materials such as prosthetic valves and tissue adhesives.
56 claims checked on air: 5 context 7 contradicted 5 overstated 29 supported 10 unverified
What they said on air - contradicted
Approximately 80% of human immune cells (white blood cells) reside in the gut.
"And you know 80% of our immune cells, our white blood cells, are down in our gut." (said at 0:18:25)
While the gastrointestinal tract is a major immunological site containing substantial mucosal-associated lymphoid tissue (and produces a large fraction of secretory antibodies such as IgA), the claim that 80% of all immune cells (white blood cells) reside in the gut is contradicted by quantitative anatomical cell surveys. Comprehensive mapping of immune cells in the human body shows that the majority of human white blood cells reside in the bone marrow (most neutrophils and precursors) and secondary lymphoid tissues such as the spleen and lymph nodes (the majority of lymphocytes), with the gut housing only a modest fraction (under 5–10%) of total immune cells.
Glyphosate (Roundup) was originally patented as an antibiotic rather than as an herbicide.
"And Roundup was patented as an antibiotic. It wasn't a weed killer." (said at 0:26:50)
The claim that glyphosate (Roundup) was originally patented as an antibiotic rather than an herbicide is contradicted by historical patent records and chemical literature. Glyphosate was first synthesized in 1950 by Swiss chemist Henri Martin at Cilag, where it was investigated as a metal chelating agent (and patented as such under Swiss Patent CH377080, later US Patent 3,160,632). Its herbicidal properties were discovered in 1970 by John E. Franz at Monsanto, leading to its registration and original patent as a broad-spectrum herbicide (US Patent 3,799,758, issued in 1974). Monsanto later obtained a patent for its antimicrobial properties in 2010 (US Patent 7,771,736), decades after its initial synthesis as a chelator and its development and marketing as an herbicide. While glyphosate does possess antimicrobial properties by inhibiting the shikimate pathway in susceptible bacteria (PMID: 41953436, PMID: 42041382), it was not originally patented or developed as an antibiotic.
Selective serotonin reuptake inhibitors (SSRIs) exert their clinical therapeutic effects by altering the gut microbiome to a favorable tryptophan-pathway microbiome rather than by blocking brain serotonin reuptake.
"And lo and behold, we now know that these drugs actually change the microbiome to a more favorable um tryptophan pathway microbiome. And so even these drugs, the effect was actually on the microbiome." (said at 0:27:20)
Selective serotonin reuptake inhibitors (SSRIs) exert their primary therapeutic effects by binding to and inhibiting the serotonin transporter (SERT) in the central nervous system, increasing synaptic serotonin concentration and downstream neuroplasticity. While recent research demonstrates that SSRIs can alter gut microbiota composition and downstream tryptophan/indole metabolites (PMID 31273200, PMID 40176389), and that baseline microbiome composition correlates with treatment response (PMID 39695082), these gut interactions are modulating or secondary effects. Evidence regarding the microbiota-gut-brain axis in psychotropic drug response remains heterogeneous and largely associative (PMID 42316492). Claiming that the therapeutic effect of SSRIs is "actually on the microbiome" rather than central serotonin reuptake inhibition contradicts established neuropharmacology.
- context: Metabolomic signature of exposure and response to citalopram/escitalopram in depressed out… (Translational psychiatry 2019) · cited 84x in the literature
"Overall, exposure to escitalopram/citalopram results in shifts in metabolism through noncanonical pathways, which suggest possible roles for the gut microbiome, oxidative stress, and inflammation-related mechanisms." (abstract, results, passage verified)
pubmedfull study (doi) - context: The role of gut microbiota and metabolomic pathways in modulating the efficacy of SSRIs fo… (Translational psychiatry 2024) · cited 36x in the literature
"In conclusion, gut microbiota influences the antidepressant effects of SSRIs through metabolic pathways. The diversity and function of gut microbiota can serve as biomarkers for predicting the treatment response, providing new insights for personalized treatment." (abstract, conclusions, passage verified)
pubmedfull study (doi) - contradicts: The Microbiota-Gut-Brain Axis: A New Frontier in Precision Neuropsychopharmacology. (Current neuropharmacology 2026)
"Although the microbiota-gut-brain axis represents a biologically plausible and clinically relevant determinant of psychotropic outcomes, current evidence remains heterogeneous and largely associative." (abstract, results, passage verified)
pubmedfull study (doi)
Color vision exists exclusively in fruit-eating animals.
"interestingly enough, uh we're fruit predators, uh and only fruit predators have color vision—um us and great apes and bees and uh so on, hummingbirds." (said at 0:51:20)
The claim that color vision exists exclusively in fruit-eating animals is contradicted by evolutionary biology and comparative visual physiology. Color vision is widespread across the animal kingdom across diverse trophic niches, including carnivores, insectivores, and aquatic predators. Ancestral vertebrates possessed multiple cone photoreceptor types enabling tetrachromatic or pentachromatic color vision, which is preserved in many modern fish, amphibians, reptiles, and birds. While the re-evolution of trichromatic color vision in catarrhine primates is hypothesized to have been influenced by foraging for ripe fruit and tender leaves, most non-frugivorous vertebrates and many non-frugivorous invertebrates (such as predatory mantis shrimp, jumping spiders, and nectar-feeding bees and hummingbirds) possess well-developed color vision.
- contradicts: Early evolution of vertebrate photoreception: lessons from lampreys and lungfishes. (Integrative zoology 2009) · cited 12x in the literature
"Detailed ultrastructural analysis reveals that all five receptor types in G. australis are cone-like, whereas N. forsteri possesses four cone types and a single type of rod. Each receptor type also contains a different visual pigment (opsin gene); that is, LWS, SWS1, SWS2, RhA and RhB in G. australis and LWS, SWS1, SWS2, Rh1 and Rh2 in N. forsteri, all of which are expressed within the retina and are sensitive to different parts of the electromagnetic spectrum, providing the potential for pentachromatic and tetrachromatic color vision, respectively." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Diverse Cell Types, Circuits, and Mechanisms for Color Vision in the Vertebrate Retina. (Physiological reviews 2019) · cited 173x in the literature
"We review studies concerning the circuit mechanisms mediating opponent interactions in a range of species, from tetrachromatic fish with diverse color opponent cell types to common dichromatic mammals where cone opponency is restricted to a subset of specialized circuits. Distinct among mammals, primates have reinvented trichromatic color vision using novel strategies to incorporate evolution of an additional photopigment gene into the foveal structure and circuitry that supports high-resolution vision." (abstract, results, passage verified)
pubmedfull study (doi)
The pharmaceutical company Eli Lilly was founded as a bacteriophage company prior to the antibiotic era.
"Eli Lilly, believe it or not, started as a bacteriophage company before the times of antibiotics." (said at 0:59:06)
Eli Lilly and Company was not founded as a bacteriophage company. The company was founded in May 1876 by Colonel Eli Lilly to manufacture standardized pharmaceutical preparations and medications—decades before bacteriophages were even discovered by Frederick Twort (1915) and Félix d'Hérelle (1917). While Eli Lilly did manufacture and commercialize bacteriophage biological products (such as Colo-lysate and Staphylo-lysate) in the 1930s during the pre-antibiotic era before abandoning them when chemical antibiotics emerged, it did not start as a bacteriophage enterprise.
About 70% of ingested fructose is absorbed through the portal vein and metabolized by the liver into uric acid and triglycerides.
"But so fructose is such a toxin that about 70% of fructose is absorbed directly through the portal vein and goes to the liver for quote, "detoxification." And it's detoxified into two compounds: uric acid and triglycerides." (said at 0:33:52)
The claim that fructose is a toxin that is 'detoxified' by the liver into only uric acid and triglycerides is contradicted by human metabolic and tracer studies. Fructose is a standard dietary carbohydrate, not a toxin. While splanchnic tissues (the gut and liver) extract a large proportion of absorbed fructose via the portal vein, its primary metabolic fates are conversion into glucose (~50%), lactate (~15–25%), glycogen (~15%), and oxidation to carbon dioxide. De novo lipogenesis into fatty acids and triglycerides accounts for only a minor fraction (typically <1–5% of an ingested load under normal physiological conditions). Uric acid is generated transiently as a minor byproduct of AMP degradation following rapid phosphorylation by ketohexokinase, not as a primary end-product or detoxification pathway.
- contradicts: Metabolic effects of fructose and the worldwide increase in obesity. (Physiological reviews 2010) · cited 1250x in the literature
"Fructose has the same chemical formula as glucose (C(6)H(12)O(6)), but its metabolism differs markedly from that of glucose due to its almost complete hepatic extraction and rapid hepatic conversion into glucose, glycogen, lactate, and fat." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Does fructose consumption contribute to non-alcoholic fatty liver disease? (Clinics and research in hepatology and gastroenterology 2012) · cited 114x in the literature
"This hexose is essentially metabolized in splanchnic tissues, where it is converted into glucose, glycogen, lactate, and, to a minor extent, fatty acids." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Metabolism of sugars: A window to the regulation of glucose and lipid homeostasis by splan… (Clinical nutrition (Edinburgh, Scotland) 2021) · cited 66x in the literature
"The gut and liver are required to process fructose and galactose into glucose, lactate, and fatty acids." (abstract, background, passage verified)
pubmedfull study (doi)
Blue light exposure stimulates hunger and ghrelin release.
"And that blue light actually served a very, very good purpose evolutionarily, because during summer we would have much longer periods of blue light, we would have blue light into the late evening, and that would stimulate us to eat because that's when the food was available, and it awakens us and it makes us hungry. It turns on ghrelin." (said at 0:56:20)
Human experimental studies examining the acute effects of blue light on appetite hormones do not support the claim that blue light stimulates hunger or activates ghrelin release. In a controlled inpatient study assessing morning and evening blue-enriched light exposure (PMID: 27191727), blue light altered glucose metabolism and reduced sleepiness, but did not significantly increase ghrelin levels or subjective hunger. Furthermore, in sleep-restricted adults (PMID: 22988459), morning blue light exposure significantly increased levels of leptin (a satiety hormone) and did not stimulate ghrelin release.
- contradicts: Light modulates leptin and ghrelin in sleep-restricted adults. (International journal of endocrinology 2012) · cited 43x in the literature
"Compared to the 5-hour sleep/dim-light condition, the red, green, and blue morning light exposures significantly increased leptin concentrations (t(1,32) = 5.7; P < 0.0001, t(1,32) = 3.6; P = 0.001, and t(1,32) = 3.0; P = 0.005, resp.). Morning red light and green light exposures significantly decreased ghrelin concentrations (t(1,32) = 3.3; P < 0.003 and t(1,32) = 2.2; P = 0.04, resp.), but morning blue light exposures did not." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Morning and Evening Blue-Enriched Light Exposure Alters Metabolic Function in Normal Weigh… (PloS one 2016) · cited 98x in the literature
"Blue-enriched light exposure acutely alters glucose metabolism and sleepiness, however the mechanisms behind this relationship and its impacts on hunger and appetite regulation remain unclear." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Fact-checked episodes
Publications